Luis
Bujanda Fernández de Piérola
Instituto de Investigación Sanitaria La Fe
Valencia, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria La Fe (13)
2023
2022
-
Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 697-705
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry
Digestive Diseases and Sciences, Vol. 66, Núm. 6, pp. 2014-2023
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection
Gastroenterologia y Hepatologia, Vol. 43, Núm. 3, pp. 117-125
2017
-
Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients
Journal of Gastroenterology, Vol. 52, Núm. 7, pp. 788-799
-
Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients (J Gastroenterol, 10.1007/s00535-016-1274-1)
Journal of Gastroenterology
2016
-
The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer
European Journal of Human Genetics, Vol. 24, Núm. 10, pp. 1501-1505
2015
-
Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer
Genetics in Medicine, Vol. 17, Núm. 2, pp. 131-142
2014
-
New genes emerging for colorectal cancer predisposition
World Journal of Gastroenterology, Vol. 20, Núm. 8, pp. 1961-1971
2011
-
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients
Alimentary Pharmacology and Therapeutics, Vol. 34, Núm. 5, pp. 544-554